<unk>  is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is FDA approved for the {{{indicationType}}} of type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia and nasopharyngitis.
Linagliptin
Liraglutide
Vildagliptin
Exenatide
Saxagliptin
Sitagliptin
Pioglitazone
Canagliflozin